This 12-week virtual learning collaborative ( April 12 to July 4, 2021) will aid participants in gaining knowledge of evidence-based monitoring parameters for efficacy and side effects for patients with serious mental illness (SMI) prescribed clozapine.
Learning objectives include:
- Identify scales relevant to implementing measurement-based care to patients who are prescribed clozapine.
- Evaluate the balance between clozapine and efficacy for control of psychiatric symptoms with that of common side effects.
- Review major organ systems for how to assess and mitigate clozapine side effects using a systematic approach.
- Develop and implement a protocol to manage efficacy and side effects for your clozapine system.
*Earn up to 12.0 AMA PRA Category 1 Credits™.